{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/CLYM/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-18T16:01:33.758Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":10143,"canonical_name":"Climb Bio, Inc.","cik":"0001768446","uei":null,"lei":null,"duns":null,"ticker":"CLYM"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":27,"clinical":1},"count":28,"timeline":[{"ts":"2026-09-17","kind":"sec.filing","form_type":"4","title":"4 — Climb Bio, Inc. — 2026-09-17","url_slug":"/sec/cik-0001768446/4/0001193125-26-394357","accession_number":"0001193125-26-394357","importance":30},{"ts":"2026-09-15","kind":"sec.filing","form_type":"144","title":"144 — Climb Bio, Inc. — 2026-09-15","url_slug":"/sec/cik-0001768446/144/0001950047-26-009491","accession_number":"0001950047-26-009491","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"8-K","title":"8-K — Climb Bio, Inc. — 2026-09-03","url_slug":"/sec/cik-0001768446/8-k/0001193125-26-381060","accession_number":"0001193125-26-381060","importance":35},{"ts":"2026-08-14","kind":"sec.filing","form_type":"8-K","title":"8-K — Climb Bio, Inc. — 2026-08-14","url_slug":"/sec/cik-0001768446/8-k/0001193125-26-350596","accession_number":"0001193125-26-350596","importance":35},{"ts":"2026-08-06","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Climb Bio, Inc. — 2026-08-06","url_slug":"/sec/cik-0001768446/10-q/0001193125-26-336774","accession_number":"0001193125-26-336774","importance":45},{"ts":"2026-08-06","kind":"sec.filing","form_type":"8-K","title":"8-K — Climb Bio, Inc. — 2026-08-06","url_slug":"/sec/cik-0001768446/8-k/0001193125-26-336762","accession_number":"0001193125-26-336762","importance":35},{"ts":"2026-07-08","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Climb Bio, Inc. — 2026-07-08","url_slug":"/sec/cik-0001768446/schedule-13g/0000315066-26-001452","accession_number":"0000315066-26-001452","importance":55},{"ts":"2026-07-01","kind":"sec.filing","form_type":"8-K","title":"8-K — Climb Bio, Inc. — 2026-07-01","url_slug":"/sec/cik-0001768446/8-k/0001193125-26-292567","accession_number":"0001193125-26-292567","importance":35},{"ts":"2026-07-01","kind":"sec.filing","form_type":"3","title":"3 — Climb Bio, Inc. — 2026-07-01","url_slug":"/sec/cik-0001768446/3/0001193125-26-292617","accession_number":"0001193125-26-292617","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — Climb Bio, Inc. — 2026-07-01","url_slug":"/sec/cik-0001768446/4/0001193125-26-292640","accession_number":"0001193125-26-292640","importance":30},{"ts":"2026-06-30","kind":"sec.form144","reporter":"AOIFE BRENNAN","title":"Officer, Director","shares":30902,"usd_value":406968,"security_title":"Common","approx_sale_date":"2026-06-29","accession_number":"0001193125-26-291127","importance":40.0813935},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Brennan Aoife","title":"President and CEO","shares":30902,"price_per_share":13.17,"usd_value":406979,"security_title":"Common Stock","importance":35.40697934},{"ts":"2026-06-29","kind":"sec.insider.30902","reporter":"Brennan Aoife","title":"President and CEO","shares":30902,"price_per_share":13.17,"usd_value":406979,"security_title":"Common Stock","importance":15.40697934},{"ts":"2026-06-27","kind":"sec.insider.68750","reporter":"Brennan Aoife","title":"President and CEO","shares":68750,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-27","kind":"sec.insider.m","reporter":"Brennan Aoife","title":"President and CEO","shares":68750,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Climb Bio, Inc. — 2026-06-12","url_slug":"/sec/cik-0001768446/8-k/0001193125-26-269567","accession_number":"0001193125-26-269567","importance":35},{"ts":"2026-06-12","kind":"sec.filing","form_type":"424B5","title":"424B5 — Climb Bio, Inc. — 2026-06-12","url_slug":"/sec/cik-0001768446/424b5/0001193125-26-269510","accession_number":"0001193125-26-269510","importance":30},{"ts":"2026-06-11","kind":"sec.filing","form_type":"8-K","title":"8-K — Climb Bio, Inc. — 2026-06-11","url_slug":"/sec/cik-0001768446/8-k/0001193125-26-266688","accession_number":"0001193125-26-266688","importance":35},{"ts":"2026-06-09","kind":"sec.filing","form_type":"424B3","title":"424B3 — Climb Bio, Inc. — 2026-06-09","url_slug":"/sec/cik-0001768446/424b3/0001193125-26-263813","accession_number":"0001193125-26-263813","importance":30},{"ts":"2026-06-09","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Climb Bio, Inc. — 2026-06-09","url_slug":"/sec/cik-0001768446/effect/9999999995-26-001931","accession_number":"9999999995-26-001931","importance":30},{"ts":"2026-06-08","kind":"sec.filing","form_type":"8-K","title":"8-K — Climb Bio, Inc. — 2026-06-08","url_slug":"/sec/cik-0001768446/8-k/0001193125-26-261716","accession_number":"0001193125-26-261716","importance":35},{"ts":"2026-06-08","kind":"sec.filing","form_type":"4","title":"4 — Climb Bio, Inc. — 2026-06-08","url_slug":"/sec/cik-0001768446/4/0001193125-26-262270","accession_number":"0001193125-26-262270","importance":30},{"ts":"2026-06-08","kind":"sec.filing","form_type":"4","title":"4 — Climb Bio, Inc. — 2026-06-08","url_slug":"/sec/cik-0001768446/4/0001193125-26-262273","accession_number":"0001193125-26-262273","importance":30},{"ts":"2026-06-08","kind":"sec.filing","form_type":"4","title":"4 — Climb Bio, Inc. — 2026-06-08","url_slug":"/sec/cik-0001768446/4/0001193125-26-262292","accession_number":"0001193125-26-262292","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"8-K","title":"8-K — Climb Bio, Inc. — 2026-06-05","url_slug":"/sec/cik-0001768446/8-k/0001193125-26-258372","accession_number":"0001193125-26-258372","importance":35},{"ts":"2026-06-05","kind":"sec.filing","form_type":"CORRESP","title":"CORRESP — Climb Bio, Inc. — 2026-06-05","url_slug":"/sec/cik-0001768446/corresp/0001193125-26-259490","accession_number":"0001193125-26-259490","importance":30},{"ts":"2026-06-04","kind":"sec.filing","form_type":"UPLOAD","title":"UPLOAD — Climb Bio, Inc. — 2026-06-04","url_slug":"/sec/cik-0001768446/upload/0000000000-26-005649","accession_number":"0000000000-26-005649","importance":30},{"ts":"2026-05-04","kind":"clinical.trial","reporter":"Climb Bio, Inc.","title":"A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE)","security_title":"PHASE1,PHASE2","status":"NOT_YET_RECRUITING","accession_number":"NCT07564596","excerpt":"[\"Systemic Lupus Erthematosus\"]","importance":45}]}